David A. Gordon

2.8k total citations
35 papers, 1.7k citations indexed

About

David A. Gordon is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, David A. Gordon has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in David A. Gordon's work include Hormonal Regulation and Hypertension (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). David A. Gordon is often cited by papers focused on Hormonal Regulation and Hypertension (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). David A. Gordon collaborates with scholars based in United States, Germany and Canada. David A. Gordon's co-authors include Haris Jamil, J. J. Wright, Bradley C. Pearce, R.A. Parker, Bernadette Kienzle, John R. Wetterau, Karen Wager‐Smith, Daniel J. Rader, Richard E. Gregg and Laura Blinderman and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

David A. Gordon

35 papers receiving 1.6k citations

Peers

David A. Gordon
Artur‐Aron Weber Germany
Hiroshi Mokuno Japan
Luı́s Vila Spain
Sonia Eligini Italy
Jacek Jawień Poland
B Jacotot France
Baohai Shao United States
Jean‐Louis Paul France
Masaharu Urakaze Japan
Haruhisa Otani Japan
Artur‐Aron Weber Germany
David A. Gordon
Citations per year, relative to David A. Gordon David A. Gordon (= 1×) peers Artur‐Aron Weber

Countries citing papers authored by David A. Gordon

Since Specialization
Citations

This map shows the geographic impact of David A. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Gordon more than expected).

Fields of papers citing papers by David A. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Gordon. The network helps show where David A. Gordon may publish in the future.

Co-authorship network of co-authors of David A. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Gordon. A scholar is included among the top collaborators of David A. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Gordon. David A. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lei, Zhaoqing Wang, Christina Ebert, et al.. (2023). Proteomic Correlates of the Urinary Protein/Creatinine Ratio in Heart Failure With Preserved Ejection Fraction. The American Journal of Cardiology. 206. 312–319. 1 indexed citations
2.
Qian, Chenao, Payman Zamani, Qasim Jehangir, et al.. (2022). Abstract 11642: Biologic Associations of the Senescence-Associated Secretory Phenotype (SASP) in Heart Failure (HF): Insights From Plasma Proteomics. Circulation. 146(Suppl_1). 1 indexed citations
3.
Chirinos, Julio A., Alena Orlenko, Lei Zhao, et al.. (2020). Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction. Journal of the American College of Cardiology. 75(11). 1281–1295. 153 indexed citations
4.
Prenner, Stuart B., Anupam Kumar, Lei Zhao, et al.. (2019). Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial). The American Journal of Cardiology. 125(4). 575–582. 30 indexed citations
5.
Yoon, David, Shung Wu, Ramakrishna Seethala, et al.. (2014). Discovery of pyridyl sulfonamide 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors for the treatment of metabolic disorders. Bioorganic & Medicinal Chemistry Letters. 24(21). 5045–5049. 14 indexed citations
6.
Ivessa, N. Erwin, E.F. Rehberg, Bernadette Kienzle, et al.. (2013). Molecular cloning, expression, and hormonal regulation of the chicken microsomal triglyceride transfer protein. Gene. 523(1). 1–9. 16 indexed citations
7.
Ye, Xiang‐Yang, Stephanie Chen, Akbar Nayeem, et al.. (2011). Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1). Bioorganic & Medicinal Chemistry Letters. 21(22). 6699–6704. 11 indexed citations
8.
Gordon, David A., et al.. (2010). Afghanistan: Building the Missing Link in the Modern Silk Road. The Washington Quarterly. 33(2). 33–47. 8 indexed citations
9.
Zhai, Weixu, Neil Flynn, Daniel Angelo Longhi, et al.. (2008). Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR). Bioorganic & Medicinal Chemistry Letters. 18(18). 5083–5086. 5 indexed citations
10.
Flynn, Michael, Mary Ellen K. Salyan, Donna L. Pedicord, et al.. (2007). Cofactor-specific modulation of 11β-hydroxysteroid dehydrogenase 1 inhibitor potency. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(9). 1184–1191. 16 indexed citations
11.
Kornowski, Ran, Martin B. Leon, Shmuel Fuchs, et al.. (2000). Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Journal of the American College of Cardiology. 35(4). 1031–1039. 105 indexed citations
12.
Gordon, David A. & Haris Jamil. (2000). Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1486(1). 72–83. 174 indexed citations
13.
14.
Keay, S., et al.. (1999). ANTIPROLIFERATIVE ACTIVITY IS PRESENT IN BLADDER BUT NOT RENAL PELVIC URINE FROM INTERSTITIAL CYSTITIS PATIENTS. The Journal of Urology. 162(4). 1487–1489. 37 indexed citations
15.
16.
Blinderman, Laura, Kelly A. Combs, Bernadette Kienzle, et al.. (1993). Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature. 365(6441). 65–69. 396 indexed citations
17.
Vinall, P., et al.. (1993). Effects of Intracisternally Injected Serotonin on Cerebral Blood Flow in Cats During Winter and Summer, and After Dark Exposure. Chronobiology International. 10(6). 442–448. 3 indexed citations
18.
El‐Ghorr, Ali A., David A. Gordon, Kelly M. George, & Eleftheria Maratos–Flier. (1992). Regulation of expression of the reovirus receptor on differentiated HL60 cells. Journal of General Virology. 73(8). 1961–1968. 4 indexed citations
19.
Gordon, David A., et al.. (1982). PROLONGATION OF KIDNEY TRANSPLANT SURVIVAL BY CYCLOSPORIN A GRAFT PRETREATMENT. Transplantation. 33(3). 329–330. 6 indexed citations
20.
Buchanan, Russell, et al.. (1981). The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy.. PubMed. 7(5). 733–6. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Artur‐Aron Weber Breakdown of academic impact, for papers by Hiroshi Mokuno Breakdown of academic impact, for papers by Luı́s Vila Breakdown of academic impact, for papers by Sonia Eligini Breakdown of academic impact, for papers by Jacek Jawień Breakdown of academic impact, for papers by B Jacotot Breakdown of academic impact, for papers by Baohai Shao Breakdown of academic impact, for papers by Jean‐Louis Paul Breakdown of academic impact, for papers by Masaharu Urakaze Breakdown of academic impact, for papers by Haruhisa Otani
Rankless by CCL
2026